← Every applicant
DiaSorin, Inc. FDA Approvals
0 new drug approvals and 10 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX510(k)Jun 4, 2026Microbiology |
| LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUREX Control Anti-HDV (318261)510(k)Dec 23, 2025Immunology |
| LIAISON VZV IgG HT, LIAISON Control VZV IgG HT510(k)Oct 27, 2023Microbiology |
| LIAISON Anti-HAV; LIAISON XS510(k)Dec 9, 2022Microbiology |
| LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus510(k)Jul 26, 2022Immunology |
| LIAISON MeMed BV, LIAISON MeMed BV Control Set510(k)Jul 14, 2022Microbiology |
| LIAISON Ferritin510(k)Sep 14, 2021Immunology |
| LIAISON Lyme IgG, LIAISON Lyme IgG Control Set, LIAISON Lyme Total Antibody Plus510(k)Feb 18, 2021Microbiology |
| LIAISON Lyme IgM, LIAISON Lyme IgM Control Set, LIAISON Lyme Total Antibody Plus510(k)Feb 18, 2021Microbiology |
| LIAISON Anti-HAV510(k)Feb 9, 2021Microbiology |